195 filings
Page 5 of 10
8-K
wehgfi7u dkfjy
27 Apr 21
Departure of Directors or Certain Officers
5:21pm
8-K
hzw d8stuz
26 Apr 21
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
8:05am
8-K
fdmzws65ufbozr
31 Mar 21
Other Events
12:00am
8-K
u6mr4
30 Mar 21
Biocardia Reports 2020 Financial Results and Recent Business Highlights
8:30am
8-K
9lhme2
29 Mar 21
Entry into a Material Definitive Agreement
4:19pm
8-K
69txdytr s48o
23 Feb 21
Biocardia Signs Agreement with Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
8:00am
8-K
sjmf6ij
17 Feb 21
Biocardia Announces Clinical Leadership Changes
8:30am
8-K
9tikgqg6dpp do4sbltj
2 Feb 21
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
8:30am
8-K
gtrj4shygr hq
11 Jan 21
Accomplished Biotech Executive Krisztina Zsebo, PH.D. Joins Biocardia’s Board of Directors
8:31am
8-K
r24rt mm0x61
28 Dec 20
Submission of Matters to a Vote of Security Holders
4:54pm
8-K/A
mx7nfz6zr0d4fhpijeu
21 Dec 20
Biocardia, Inc. Announces $10.5 Million
5:28pm
8-K
1itlz
17 Dec 20
Biocardia Announces Positive DSMB Futility Analysis Review and Recommendation to Continue Phase Iii
8:30am
8-K
uwptxy7fk
16 Dec 20
Biocardia, Inc. Announces $8.5 Million
6:02am
8-K
vh5c7 q16ku6xoyaqei
15 Dec 20
Biocardia, Inc. Announces $8.5 Million
4:08pm
8-K
4hzmx4
14 Dec 20
Other Events
2:28pm
8-K
aljefxoalq nn9x
1 Dec 20
Regulation FD Disclosure
8:00am
8-K
gr61kcc
13 Nov 20
Changes in Registrant's Certifying Accountant
12:00am
8-K
b3tiqo 2uvp2v6
27 Oct 20
Paper published in the “International Journal of Cardiology” demonstrates safety and tolerability while showing functional improvement at six months
7:30am
8-K
ko5b4
9 Oct 20
Other Events
7:30am
8-K
30g8de4 yqs8pzf9
13 Aug 20
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
6:11am